I was here first! This is how hepatitis C inhibits hepatitis E
A single protein from one virus can prevent infection with another virus in cell culture
© Abteilung für Molekulare und Medizinische Virologie
It is well known that co-infections with hepatitis viruses do exist. “However, the co-infection of hepatitis C and E has not yet been systematically researched,” says Thomas Burkard. “Even though the possibility always looms that a simultaneous infection with two viruses could perhaps be particularly dangerous.”
A single protein suppresses infection
In order to find out more about simultaneous infection with the hepatitis C (HCV) and hepatitis E virus (HEV), the researchers infected liver cells in cell culture with both pathogens in the first step. It turned out that HCV is able to suppress an infection with hepatitis E. The team wanted to find out why. “HCV consists of ten proteins,” explains Thomas Burkard. “By producing individual ones in excess, we were able to study their effect.” This allowed the researchers to find that a single viral protein – called NS3/4A – successfully suppressed the replication of hepatitis E viruses in cell culture. “It seemed that co-infection with both viruses was only possible to a very limited extent,” says Thomas Burkard.
Experiments in animal models, however, presented a different pattern: genetically modified mice that have a human liver could become infected with both viruses. However, the infections proceeded in different ways depending on which one the mice were exposed to first. If HEV was present first, HCV could not successfully infect the animals. If HCV was present first, the infection course with HEV was often delayed. “Here, HCV did not turn out to be as dominant as in cell culture,” says Thomas Burkard. In-depth analyses of the liver cells should now shed light on the underlying causes: “Perhaps we will only find islets that are infected with one or the other virus,” speculates the researcher. “In any case, it is clear that the two viruses affect each other.”
Original publication
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.